
We are proud to announce strategic partnerships that add robustness to our differentiated #biomarker-driven strategy, allowing us to broaden the impact of our #KIF18A inhibitor medicines for #cancer patients. Learn more here: bit.ly/43wTtlE. #chromosomal_instability








